首页> 美国卫生研究院文献>Biotechnology Reports >Development of an aptamer-based affinity purification method for vascular endothelial growth factor
【2h】

Development of an aptamer-based affinity purification method for vascular endothelial growth factor

机译:基于适配子的血管内皮生长因子亲和纯化方法的开发

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Since aptamers bind their targets with high affinity and specificity, they are promising alternative ligands in protein affinity purification. As aptamers are chemically synthesized oligonucleotides, they can be easily produced in large quantities regarding GMP conditions allowing their application in protein production for therapeutic purposes. Several advantages of aptamers compared to antibodies are described in general within this paper. Here, an aptamer directed against the human Vascular Endothelial Growth Factor (VEGF) was used as affinity ligand for establishing a purification platform for VEGF in small scale. The aptamer was covalently immobilized on magnetic beads in a controlled orientation resulting in a functional active affinity matrix. Target binding was optimized by introduction of spacer molecules and variation of aptamer density. Further, salt-induced target elution was demonstrated as well as VEGF purification from a complex protein mixture proving the specificity of protein-aptamer binding.
机译:由于适体以高亲和力和特异性结合其靶标,因此它们在蛋白质亲和纯化中是有希望的替代配体。由于适体是化学合成的寡核苷酸,因此就GMP条件而言,它们很容易大量生产,从而可将它们应用于治疗目的的蛋白质生产中。与抗体相比,适体的一些优势已在本文中进行了概述。在这里,针对人血管内皮生长因子(VEGF)的适体被用作亲和配体,以建立小规模的VEGF纯化平台。适体以受控的取向共价固定在磁珠上,从而产生功能性活性亲和基质。通过引入间隔子分子和适体密度的变化来优化靶标结合。此外,还证明了盐诱导的靶标洗脱以及从复杂蛋白混合物中纯化VEGF,证明了蛋白-适体结合的特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号